Showing results (571-580 of 722) with videos related to

Sort By:
Pageof 73
JMIR Research Protocols|January 28, 2021
Evaluating the Effectiveness of an E-Mental Health Intervention for People Living in Lebanon: Protocol for Two Randomized Controlled TrialsEdith van 't Hof, Eva Heim, Jinane Abi Ramia, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2007
Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary interventionM B Nienhuis, J P Ottervanger, J-H E Dambrink, et al.
Thrombosis and Haemostasis|May 12, 2005
Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Jaap J Smit, Nicolette Ernst, et al.
Thrombosis and Haemostasis|August 9, 2006
Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarctionJaap Jan J Smit, Arnoud W J van 't Hof, Menko Jan de Boer, et al.
Plos One|July 16, 2015
No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary SyndromeJudith M Poldervaart, Emma Röttger, Marieke S Dekker, et al.
The Netherlands Journal of Medicine|March 28, 2007
Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMIS Rasoul, J P Ottervanger, H J G Bilo, et al.
European Heart Journal. Acute Cardiovascular Care|February 15, 2019
Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trialsNiels Pg Hoedemaker, Vincent Roolvink, Robbert J de Winter, et al.
European Heart Journal|May 23, 2014
Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trialUwe Zeymer, Arnoud van 't Hof, Jennifer Adgey, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 2, 2025
Mass balance and metabolite profiling of 14C-Zalunfiban in humans following single-dose subcutaneous administrationRobert B MacArthur, Sem A O F Rikken, Spandana R Vootukuri, et al.
Ecotoxicology and Environmental Safety|August 31, 2024
Mitigating lead-induced osteoporosis: The role of butyrate in gut-bone axis restorationYuqiu Ge, Zhongtang Jia, Shiting Zhao, et al.
Pageof 73